Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I)Felix Popp, Marc H. Dahlke, Elke Eggenhofer et al.|Journal of Translational Medicine|2011Cited by 51